Initial Low‐Dose Gentamicin forStaphylococcus aureusBacteremia and Endocarditis Is Nephrotoxic
Clinical Infectious Diseases2009Vol. 48(6), pp. 713–721
Citations Over TimeTop 1% of 2009 papers
Sara E. Cosgrove, Gloria Vigliani, Marilyn Campion, Vance G. Fowler, Elías Abrutyn, G. Ralph Corey, Donald P. Levine, Mark E. Rupp, Henry F. Chambers, Adolf W. Karchmer, Helen W. Boucher
Abstract
Initial low-dose gentamicin as part of therapy for S. aureus bacteremia and native valve infective endocarditis is nephrotoxic and should not be used routinely, given the minimal existing data supporting its benefit.
Related Papers
- → Nephrotoxicity of the Constituents of the Gentamicin Complex(1984)27 cited
- → The enhancement of cyclosporin a-induced nephrotoxicity by gentamicin(1983)24 cited
- → Pharmacologic limits of the protective effect of polyaspartic acid on experimental gentamicin nephrotoxicity(1993)14 cited
- → Role of individual structural features of rabbit kidneys in the predisposition to gentamicin nephrotoxicity(2004)3 cited
- → Comparative Effect of NR-AG-I and NR-AG-II (Polyherbal formulations) against Gentamicin - Induced Nephrotoxicity in Rats(2001)